Oscar Health CEO Buys 1 Million Shares

Bertolini's purchase represents a 10.87% increase in his ownership stake.

Apr. 7, 2026 at 10:10pm

Got story updates? Submit your updates here. ›

An extreme close-up of intricate, interlocking gears and levers in a banking vault, conveying a sense of institutional stability and financial security.Oscar Health's CEO's million-dollar investment signals confidence in the company's financial infrastructure and future growth.NYC Today

Oscar Health, Inc. (NYSE:OSCR) CEO Mark Bertolini acquired 1,000,000 shares of the company's stock on Monday, April 6th. The shares were purchased at an average price of $11.92 per share, for a total transaction of $11,920,000. Following the acquisition, Bertolini now owns 10,196,876 shares of Oscar Health, valued at approximately $121,546,761.92.

Why it matters

This significant insider purchase by the CEO signals Bertolini's confidence in Oscar Health's future prospects and could be seen as a positive sign for investors. Insider buying is often viewed as a bullish indicator, as company leaders typically have the best insight into a firm's operations and growth potential.

The details

Bertolini's purchase represents a 10.87% increase in his ownership stake in Oscar Health. The transaction was disclosed in a filing with the Securities and Exchange Commission. Oscar Health is a technology-driven health insurance company that offers individual, family, and Medicare Advantage plans.

  • The share purchase occurred on Monday, April 6th, 2026.

The players

Mark Bertolini

The CEO of Oscar Health, Inc.

Oscar Health, Inc.

A technology-driven health insurance company that offers individual, family, and Medicare Advantage plans.

Got photos? Submit your photos here. ›

What’s next

Investors will likely continue to monitor Oscar Health's stock performance and any further insider buying or selling activity by Bertolini and other company executives.

The takeaway

Bertolini's substantial purchase of Oscar Health shares suggests he believes the company is undervalued and has strong growth potential, which could be a positive signal for investors considering the stock.